Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Simvastatin: Multiple Sclerosis.

Generali JA, Cada DJ.

Hosp Pharm. 2015 Jun;50(6):464-6. doi: 10.1310/hpj5006-464.

PMID:
26405337
2.

Atorvastatin: multiple sclerosis.

Generali JA, Cada DJ.

Hosp Pharm. 2014 Nov;49(10):920-2. doi: 10.1310/hpj4910-920.

3.

Astragalosides from Radix Astragali benefits experimental autoimmune encephalomyelitis in C57BL /6 mice at multiple levels.

He YX, Du M, Shi HL, Huang F, Liu HS, Wu H, Zhang BB, Dou W, Wu XJ, Wang ZT.

BMC Complement Altern Med. 2014 Aug 24;14:313. doi: 10.1186/1472-6882-14-313.

4.

Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial.

Kamm CP, El-Koussy M, Humpert S, Findling O, Burren Y, Schwegler G, Donati F, Müller M, Müller F, Slotboom J, Kappos L, Naegelin Y, Mattle HP; SWABIMS Study Group.

PLoS One. 2014 Jan 30;9(1):e86663. doi: 10.1371/journal.pone.0086663. eCollection 2014.

5.

Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?

Davidson DC, Jackson JW, Maggirwar SB.

J Neuroinflammation. 2013 Dec 1;10:144. doi: 10.1186/1742-2094-10-144. Review.

6.

Role of statins in the development and progression of age-related macular degeneration.

VanderBeek BL, Zacks DN, Talwar N, Nan B, Stein JD.

Retina. 2013 Feb;33(2):414-22. doi: 10.1097/IAE.0b013e318276e0cf.

7.

Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients.

Molnarfi N, Benkhoucha M, Bjarnadóttir K, Juillard C, Lalive PH.

PLoS One. 2012;7(11):e49882. doi: 10.1371/journal.pone.0049882. Epub 2012 Nov 14.

8.

Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial.

Kamm CP, El-Koussy M, Humpert S, Findling O, von Bredow F, Burren Y, Schwegler G, Schött D, Donati F, Müller M, Goebels N, Müller F, Slotboom J, Tettenborn B, Kappos L, Naegelin Y, Mattle HP.

J Neurol. 2012 Nov;259(11):2401-13. doi: 10.1007/s00415-012-6513-7. Epub 2012 May 9.

9.

Statin effects on regulatory and proinflammatory factors in chronic idiopathic urticaria.

Azor MH, dos Santos JC, Futata EA, de Brito CA, Maruta CW, Rivitti EA, da Silva Duarte AJ, Sato MN.

Clin Exp Immunol. 2011 Nov;166(2):291-8. doi: 10.1111/j.1365-2249.2011.04473.x.

10.

Statins are active in acute lymphoblastic leukaemia (ALL): a therapy that may treat ALL and prevent avascular necrosis.

Sheen C, Vincent T, Barrett D, Horwitz EM, Hulitt J, Strong E, Grupp SA, Teachey DT.

Br J Haematol. 2011 Nov;155(3):403-7. doi: 10.1111/j.1365-2141.2011.08696.x. Epub 2011 May 9. No abstract available.

11.

Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

McMahon M, Hahn BH, Skaggs BJ.

Expert Rev Clin Immunol. 2011 Mar;7(2):227-41. doi: 10.1586/eci.10.98. Review.

12.
13.

Fluvastatin inhibits expression of the chemokine MDC/CCL22 induced by interferon-gamma in HaCaT cells, a human keratinocyte cell line.

Qi XF, Kim DH, Yoon YS, Li JH, Jin D, Teng YC, Kim SK, Lee KJ.

Br J Pharmacol. 2009 Aug;157(8):1441-50. doi: 10.1111/j.1476-5381.2009.00311.x. Epub 2009 Jul 7.

15.

The IFN-gamma-induced transcriptional program of the CIITA gene is inhibited by statins.

Lee SJ, Qin H, Benveniste EN.

Eur J Immunol. 2008 Aug;38(8):2325-36. doi: 10.1002/eji.200838189.

16.

Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis.

Paul F, Waiczies S, Wuerfel J, Bellmann-Strobl J, Dörr J, Waiczies H, Haertle M, Wernecke KD, Volk HD, Aktas O, Zipp F.

PLoS One. 2008 Apr 9;3(4):e1928. doi: 10.1371/journal.pone.0001928.

17.

Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis.

Sellner J, Greeve I, Findling O, Grandgirard D, Leib SL, Mattle HP.

Clin Exp Immunol. 2008 May;152(2):280-4. doi: 10.1111/j.1365-2249.2008.03630.x. Epub 2008 Mar 12.

18.
19.

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation.

Greenwood J, Steinman L, Zamvil SS.

Nat Rev Immunol. 2006 May;6(5):358-70. Review.

20.

Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity.

Stüve O, Youssef S, Weber MS, Nessler S, von Büdingen HC, Hemmer B, Prod'homme T, Sobel RA, Steinman L, Zamvil SS.

J Clin Invest. 2006 Apr;116(4):1037-44. Epub 2006 Mar 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk